Poorly differentiated adenocarcinoma of an unknown primary with a thyroid tumour and an aggressive course: Thyroid or lung carcinoma?

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Cancers of unknown primary (CUPs) are challenging for physicians to diagnose and treat. Metastases to the thyroid gland are rare, representing less than 1% of all thyroid malignancies. Here, we report a case of a 69-year-old Asian man who had both thyroid gland and lymph node enlargement in the neck and shoulders but no nodules/tumours in the lung field. The patient died 51 days after his first visit to our office, although pembrolizumab was administered on day 34 based on programmed cell death-ligand 1 (PD-L1) expression. Immunohistochemistry (IHC) with paired box 8 (PAX8) may be useful to diagnostically distinguish poorly differentiated lung adenocarcinomas from napsin A-positive thyroid carcinomas.

Cite

CITATION STYLE

APA

Ito, T., Yoshida, T., Sakai, T., Watanabe, K., Nishimura, H., Hamada, K., & Ito, A. (2019). Poorly differentiated adenocarcinoma of an unknown primary with a thyroid tumour and an aggressive course: Thyroid or lung carcinoma? Oxford Medical Case Reports, 2019(4), 165–168. https://doi.org/10.1093/omcr/omy129

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free